Therapeutic intervention in cardiovascular diseases

Group leader: José Manuel Porres, M.D.

Donostialdea IHO josemanuel.porresaracama@osakidetza.eus

Strategic Objectives

  • Contribution to the Health Service’s development through improvements in clinical practice:
    • Intensive Care Medicine Service.
    • Cardiology Service.
    • Primary healthcare.

Main lines of research

  • Ischemic Heart Disease:
    •  SCASEST.
    • IAM.
  • Heart Failure:
    • Cardiac resynchronisation.
    • New access to the left ventricle.
  • Arrhythmia:
    • Location and diagnosis.
    • Electrical treatment.
    • Formation.
    • Follow-up.

Team Members

Name Surname
Center E-mail
Jose Jesús Artaechevarria Zuazo Donostialdea IHO josej.artaecheverriazuazo@osakidetza.eus
Francisco García Urra Donostialdea IHO francisco.garciaurra@osakidetza.eus
Antonio Oscar Luque Lezcano Donostialdea IHO antoniooscar.luquelezcano@osakidetza.eus
Pedro Morrondo Valdeolmillos Donostialdea IHO pedro.morrondovaldeolmillos@osakidetza.eus
Vicente Urbistondo Ayestarán Donostialdea IHO vicente.urbistondoayestaran@osakidetza.eus
Felix Zubia Olaskoaga Donostialdea IHO felix.zubiaolascoaga@osakidetza.eus

 

Scientific Output

Originals

Published: 10 / 16

PANCREA. Determinant-Based Classification of Acute Pancreatitis Severity An International Multidisciplinary Consultation.

Dellinger EP, Forsmark CE, Layer P, Levy P, Maravi-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo, Generoso, Whitcomb, David C., Windsor, John A.,

Ann. Surg. 2012; 256: 875-880. FI: 7.492 (Q1).

Paddle-Wheel Shaped Copper(II)-Adenine Discrete Entities As Supramolecular Building Blocks To Afford Porous Supramolecular Metal-Organic Frameworks (SMOFs).

Thomas-Gipson J, Beobide G, Castillo O, Froeba M, Hoffmann F, Luque A, Perez-Yanez S, Roman P.

Cryst. Growth Des. 2014; 14: 4019-4029. FI: 4.558 (Q1).

H1N1 SEMICYUC-CIBERES-REIPI. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.

Díaz E, Martín-Loeches I, Canadell L, Vidaur L, Suárez D, Socias L, Estella A, Gil Rueda B, Guerrero JE, Valverdu-Vidal M, Vergara JC, López-Pueyo MJ, Magret M, Recio T, López D, Rello J, Rodríguez A.

J. Infect. 2012; 64: 311-318. FI: 4.126 (Q1).

Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.

Selga E, Campuzano O, Lina Pinsach-Abuin M, Perez-Serra A, Mademont-Soler I, Riuro H, Pico F, Coll M, Iglesias A, Pagans S, Sarquella-Brugada G, Berne P, Benito B, Brugada J, Porres JM, Lopez M, Castro-Urda V, Fernandez-Lozano I, Brugada R.

LoS One. 2015; 10. FI: 3.234 (Q1).

Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.

Anguera I, Dallaglio P, Martínez-Ferrer J, Rodríguez A, Alzueta J, Pérez-Villacastín J, Porres JM, Viñolas X, Fontenla A, Fernández-Lozano I, García-Alberola A, Sabaté X.

J. Cardiovasc. Electrophysiol. 2015; 26: 774-782. FI: 2.958 (Q2).

Candida albicans endocarditis in a patient with an implantable cardioverter defibrillator (ICD).

Eguibar-Villimar I, Porres-Aracama JM, Azcarate-Ayerdi B, Salaberri R.

Enferm. Infec. Microbiol. Clin. 2015; 33: 213-214. FI: 2.172 (Q3).

Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.

Canadell L, Martín-Loeches I, Díaz E, Trefler S, Grau S, Yebenes JC, Almirall J, Olona M, Sureda F, Blanquer J, Rodriguez A, GETGAG.

Med. Intensiv. 2015; 39: 222-233. FI: 1.336 (Q4).

SEMICYUC 2012. Recommendations for intensive care management of acute pancreatitis.

Maravi E, Zubia F, Petrov MS, Navarro S, Laplaza C, Morales F, Darnell A, Gorraiz B, Bolado F, Casi M, Aizcorbe M, Albeniz E, Sanchez-Izquierdo JA, Tirapu JP, Bordeje L, Lopez V, Marcos-Neira P, Regidor E, Jimenez F, GTEI-SEMICYUC.

Med. Intensiv. 2013; 37: 163-179. FI: 1.323 (Q4).

Spanish Soc Intensive Care Med, Critical Coronary Units GTCICyRCP.

García Urra F, Luque Lezcano AO.

MAMI registration report 1996-2010. Cardiol. J. 201; 19: 603-611. FI: 1.309 (Q3).

Cardiac `resynchronization’ by a left lateral accessory pathway.

Luque Lezcano AO, Porres Aracama JM, García Urra F, Urbistondo Ayestaran V.

Cardiol. J. 2012; 19: 536-538. FI: 1.309 (Q3).

Reviews

Published: 0 / 0

Editorials

Published: 1 / 1

Adenosine and proarrhythmia in patients with Wolf-Parkinson-White syndrome.

Porres JM, Luque O, Garcia F.

Med. Intensiv. 2013; 37: 125-0. FI: 1.323 (Q4).

Letters

Published: 2 / 2

Epidemic nephropathy due to Puumala virus: A case report.

Fuertes-Rodriguez A, Atutxa-Bizkarguenaga L, Aranegui-Lasuen P, Zubia-Olaskoaga F.

Enferm. Infec. Microbiol. Clin. 2014; 32: 472-473. FI: 1.881 (Q3).

Cardiac resynchronization therapy: 6 year experience of a comprehensive follow-up protocol.

Luque-Lezcano AO, Porres-Aracama JM, Garcia-Urra F, Urbistondo-Ayestaran V, Garcia-Martin R, Marco-Garde P.

Med. Intensiv. 2013; 37: 497-498. FI: 1.323 (Q4).

Others

Published: 2 / 2

Terapias ATP y “modo Smart”: a propósito de un caso.

Porres JM, Luque AO, Garcia F, Bosch E.

Cuadernos de Estimulación Cardiaca. 2013; 6 (17): 81-84. FI: 0.000 (Q0).

Dispositivos eléctricos y monitorización remota.

Garcia F, Porres JM, Fontán B, Chico M.

Rev. Urug. Cardiol. 2013; 28: 63-70. FI: 0.000 (Q0).

Projects

Projects

Este grupo no tiene Projects